Report Detail
Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights, Forecast to 2025
- RnM2896918 |
- 07 February, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The global Human Cytomegalovirus Envelope Glycoprotein B market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Cytomegalovirus Envelope Glycoprotein B market based on company, product type, end user and key regions.
This report studies the global market size of Human Cytomegalovirus Envelope Glycoprotein B in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Cytomegalovirus Envelope Glycoprotein B in these regions.
This research report categorizes the global Human Cytomegalovirus Envelope Glycoprotein B market by top players/brands, region, type and end user. This report also studies the global Human Cytomegalovirus Envelope Glycoprotein B market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Market size by Product
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Market size by End User
Infectious Disease
Oncology
Women's Health
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Human Cytomegalovirus Envelope Glycoprotein B market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Cytomegalovirus Envelope Glycoprotein B market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Cytomegalovirus Envelope Glycoprotein B companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Cytomegalovirus Envelope Glycoprotein B submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Human Cytomegalovirus Envelope Glycoprotein B are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Cytomegalovirus Envelope Glycoprotein B market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Human Cytomegalovirus Envelope Glycoprotein B Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Product
- 1.4.2 CSJ-148
- 1.4.3 CyMVectin
- 1.4.4 TRL-345
- 1.4.5 PPCM
- 1.4.6 Cytomegalovirus Vaccine
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by End User
- 1.5.2 Infectious Disease
- 1.5.3 Oncology
- 1.5.4 Women's Health
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size
- 2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2014-2025
- 2.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2014-2025
- 2.2 Human Cytomegalovirus Envelope Glycoprotein B Growth Rate by Regions
- 2.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Regions
- 2.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers
- 3.1.1 Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers
- 3.1.2 Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers
- 3.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Ratio (CR5 and HHI)
- 3.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers
- 3.2.1 Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2014-2019)
- 3.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturers
- 3.4 Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base Distribution, Product Types
- 3.4.1 Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Cytomegalovirus Envelope Glycoprotein B Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Product
- 4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Product
- 4.3 Human Cytomegalovirus Envelope Glycoprotein B Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by End User
6 North America
- 6.1 North America Human Cytomegalovirus Envelope Glycoprotein B by Countries
- 6.1.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Countries
- 6.1.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Human Cytomegalovirus Envelope Glycoprotein B by Product
- 6.3 North America Human Cytomegalovirus Envelope Glycoprotein B by End User
7 Europe
- 7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Countries
- 7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Countries
- 7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B by Product
- 7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B by End User
8 Asia Pacific
- 8.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B by Countries
- 8.1.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Countries
- 8.1.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B by Product
- 8.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B by End User
9 Central & South America
- 9.1 Central & South America Human Cytomegalovirus Envelope Glycoprotein B by Countries
- 9.1.1 Central & South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Countries
- 9.1.2 Central & South America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Human Cytomegalovirus Envelope Glycoprotein B by Product
- 9.3 Central & South America Human Cytomegalovirus Envelope Glycoprotein B by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B by Countries
- 10.1.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Countries
- 10.1.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B by Product
- 10.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B by End User
11 Company Profiles
- 11.1 Astellas Pharma Inc.
- 11.1.1 Astellas Pharma Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
- 11.1.5 Astellas Pharma Inc. Recent Development
- 11.2 Trellis Bioscience, Inc.
- 11.2.1 Trellis Bioscience, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Products Offered
- 11.2.5 Trellis Bioscience, Inc. Recent Development
- 11.3 Vakzine Projekt Management GmbH
- 11.3.1 Vakzine Projekt Management GmbH Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Products Offered
- 11.3.5 Vakzine Projekt Management GmbH Recent Development
- 11.4 VBI Vaccine Inc
- 11.4.1 VBI Vaccine Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Products Offered
- 11.4.5 VBI Vaccine Inc Recent Development
- 11.5 Vical Incorporated
- 11.5.1 Vical Incorporated Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Products Offered
- 11.5.5 Vical Incorporated Recent Development
12 Future Forecast
- 12.1 Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Regions
- 12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Regions 2019-2025
- 12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Regions 2019-2025
- 12.2 Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by Product
- 12.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Product 2019-2025
- 12.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Product 2019-2025
- 12.3 Human Cytomegalovirus Envelope Glycoprotein B Market Forecast by End User
- 12.4 North America Human Cytomegalovirus Envelope Glycoprotein B Forecast
- 12.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Forecast
- 12.6 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Forecast
- 12.7 Central & South America Human Cytomegalovirus Envelope Glycoprotein B Forecast
- 12.8 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Cytomegalovirus Envelope Glycoprotein B Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Cytomegalovirus Envelope Glycoprotein B . Industry analysis & Market Report on Human Cytomegalovirus Envelope Glycoprotein B is a syndicated market report, published as Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Cytomegalovirus Envelope Glycoprotein B market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
